Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NMDA receptor’s glycine site is an obligatory coagonist recognition pocket located on its essential GluN1/NR1 subunits. Occupancy by either endogenous ligands like glycine or D-serine enables full activation only when coupled with concurrent glutamate binding at adjacent sites. This dual-ligand gating underpins many key processes in CNS physiology while also providing pharmacological opportunities for therapeutic intervention targeting cognitive function or neuroprotection through modulation at this unique allosteric regulatory node within excitatory synapses.
Modulation of NMDA receptor activity via the glycine co-agonist binding site.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA (Glycine Site) (NMDA receptor (glycine site)).